跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TYKERB lapatinib 250mg (as ditosilate monohydrate) tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
TYKERB lapatinib 250mg (as ditosilate monohydrate) tablet bottle
Approved
STANDARD
TYKERB lapatinib 250mg (as ditosilate monohydrate) tablet bottle
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b064077c23a9a6d6
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b064077c23a9a6d6
Product Name
TYKERB lapatinib 250mg (as ditosilate monohydrate) tablet bottle
Artg Id
185997
Artg Name
TYKERB lapatinib 250mg (as ditosilate monohydrate) tablet bottle
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2011-09-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01998-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01919-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b064077c23a9a6d6
Type
Standard
Back to TGA Approvals
